ARHGDIB Antikörper
Kurzübersicht für ARHGDIB Antikörper (ABIN207935)
Target
Alle ARHGDIB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- In anti-Fas treated Jurkat, an approx. 23 kD band should be observed.
-
Aufreinigung
- Protein G purified
-
Immunogen
-
A synthetic peptide corresponding to the region of the Fas-induced cleavage site of human D4-GDI.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: Flo, IHC (2 μg/mL), IP (1 - 2 μg/mL), WB (2 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.05 % BSA, 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
- ARHGDIB (rho GDP Dissociation Inhibitor (GDI) beta (ARHGDIB))
-
Andere Bezeichnung
- ARHGDIB / D4 GDI
-
Hintergrund
-
Name/Gene ID: ARHGDIB
Synonyms: ARHGDIB, D4 GDI, D4-GDI, GDIA2, Ly-GDI, RAP1GN1, Rho-GDI beta, RhoGDI2, Rho GDI 2, D4, GDID4, LYGDI -
Gen-ID
- 397
-
UniProt
- P52566
-
Pathways
- Caspase Kaskade in der Apoptose
Target
-